Ligne de temps
Laurine Levillayer
Technicien(ne)
03 févr. 2023
publication
Tocilizumab treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants.
Lire plus21 nov. 2022
publication
SKAP2 modular organization differently recognizes SRC kinases depending on their activation status and localization.
Lire plus01 nov. 2021
publication
A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters
Lire plus29 sept. 2021
09 oct. 2020
21 juin 2019
publication
A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice
Lire plus11 oct. 2018
project
miRNA involvement in resistance to infection by Dengue virus : miRNA transcriptome on monocytes of individuals “Susceptible” or “Resistant” following in vitro infection by DENV2
Lire plus08 oct. 2018
08 oct. 2018
project
T cell immunity to dengue virus infection in transgenic mice expressing human HLA molecules
Lire plus11 mai 2015